Education
About Us
Working with TipRanks
Follow Us
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Earnings Data
Report Date
Mar 26, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
0.49Last Year’s EPS
0.29Same Quarter Last Year
Moderate Buy
Based on 5 Analysts Ratings
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) Earnings, Revenues Date & History
HK:1276 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:1276 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 24, 2025 | HK$76.30 | HK$76.80 | +0.66% |
Aug 18, 2025 | HK$82.05 | HK$83.50 | +1.77% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) report earnings?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) is schdueled to report earning on Mar 26, 2026, TBA (Confirmed).
What is Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) earnings time?
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276) earnings time is at Mar 26, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H stock?
The P/E ratio of Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H is N/A.
What is HK:1276 EPS forecast?
HK:1276 EPS forecast for the fiscal quarter 2025 (Q4) is 0.49.